Chris Chai and Peter Van Vlasselaer, both former executives at SR One portfolio companies, have been hired by the GSK-backed VC firm as venture partners.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The stealthy consumer device startup took its total funding to $22m in just four months, with Alphabet unit GV leading its series A round.

A round up of the week's new fund and incbuator launches.

Today's deal net contains news from RAW Labs, Neuropain Therapeutics and Swajal.

Swisscom Ventures participated in a round that lifted the total raised by the laboratory simulation software provider to $104m.

Boeing HorizonX and SES Engineering both strapped themselves into the satellite technology developer's latest round, bringing its overall funding to about $60m.

Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.

GV returned for SpyBiotech's $32.5m series A round, as it looks to move its first potential vaccine into the clinic by early next year.

Vienna Insurance is among the limited partners for a $48m seed-stage fund aimed at university spinouts in Austria.